Healthcare Providers as Trusted Messengers to Increase Receipt of Tax Credits Among Low-income Families

Sponsor
University of California, Los Angeles (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05612685
Collaborator
(none)
100
1
78

Study Details

Study Description

Brief Summary

The purpose of this study is to pilot test the feasibility, acceptability, and preliminary efficacy of healthcare provider referrals to a tax filing app within parent-child health programs to test whether such referrals can increase receipt of tax credits among low-income parents. The study will use a single-group, pre/post test design with a sample of approximately 100 women who have a child under 6 years of age. Participants will be recruited from parental-child health programs and clinics in Los Angeles and will complete surveys at baseline, immediately after tax filing season, and six months after tax filing season to assess 1) frequency of tax filing after referral (Feasibility), 2) the acceptability of the tax filing app from the perspective of users (Acceptability), and 3) pre/posttest changes to parent and child health, child development, and healthcare utilization measures for users (preliminary efficacy).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Healthcare provider referral to a tax filing app
N/A

Detailed Description

Aims: The purpose of this study is to pilot test the feasibility, acceptability, and preliminary efficacy of healthcare provider referrals to a tax filing app within parental-child health programs whether such referrals can increase receipt of tax credits among low-income parents. The study will use a single-group, pre/posttest design. The primary outcome is feasibility, defined as whether or not participants filed taxes after referral. Secondary outcomes are acceptability of the app and preliminary efficacy of the app on improved parent and child health. Specific aims are to:

  1. assess frequency of tax filing among parents referred to a tax filing app (Primary outcome/Feasibility)

  2. examine the acceptability of a tax filing app from the perspective of users (Secondary outcome/Acceptability), and

  3. explore pre/posttest changes to parent and child health, child development, and healthcare utilization measures for users the app after referral (Secondary outcome/Preliminary efficacy).

Design: This pilot study will use a single-group, pre/post-test design to assess the feasibility, acceptability, and preliminary efficacy of healthcare provider referrals to a tax filing app.

Intervention: Referrals to a tax filing app

Setting: The setting for this study is maternal/child health programs and clinics in Los Angeles.

Sample: The target population is parents making less than $75,000 per year in income . Parents will be eligible to participate in the study if they are within the income threshold, have one or more children under six years of age, speak English or Spanish, have access to an internet-enabled device (smart phone or tablet), and have a valid tax filing ID (SSN or ITIN). Parents will be ineligible if they have already filed taxes during the study period or are experiencing an acute mental health crisis (e.g., suicidality). We focus on children under six years of age because this is a critical and sensitive developmental window when interventions have potential for outsized impact on child health.

Procedures: Parents will be recruited during program visits/encounters early in tax season in 2023. Those that provide informed consent to participate in the study will complete a baseline survey and receive the assigned intervention (referral to a tax filing app) the same day or within the same week of their program visit. Parents will complete a follow-up survey to assess outcome measures after they receive tax refunds. A second follow-up survey will be sent 3-6 months later (depending on time of filing, and average time of receipt of tax credit this season) to assess medium-term outcomes.

Outcomes. We will assess the following outcomes. The primary study outcome is feasibility; acceptability and preliminary health efficacy are secondary outcomes.

Feasibility: Self-reported tax filing (items developed for this study) Acceptability: Health app acceptability measure (Chen et al., 2022) Preliminary efficacy: We will assess pre/posttest changes in the following health-related measures as indicators of preliminary efficacy: 1a) parent health (PROMIS® Scale v1.2 - Global Health [Hays et al., 2009]; Patient Health Questionnaire- 2 [Kroenke et al., 2003); Perceived Stress Scale [Cohen et al., 1994]; PROMIS®-29 Profile v2.1 [Hays et al., 2018]) and 1b) child health (PROMIS® Early Childhood Parent Report Global Health [Forrest et al., 2014]); 2) child development (PEDS-DM [Pritchard et al., 2012]); and 3) and 4) healthcare utilization (adapted from survey items by Patrick et al,. 2020 for this study).

Demographic and family health background information (see survey: age, gender, race/ethnicity, income, social determinants of health, health background, other tax filing characteristics) will be collected to identify characteristics of the sample. In future studies, we intend to study in greater depth the physical health outcomes that might be sensitive to this intervention with longer-term follow up.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Healthcare Providers as Trusted Messengers to Increase Receipt of Tax Credits Among Low-income Families
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2028
Anticipated Study Completion Date :
Jul 1, 2029

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

This arm will receive a healthcare provider referral to a tax filing app

Behavioral: Healthcare provider referral to a tax filing app
Healthcare providers offer a referral to a tax filing app and briefly describe the potential benefits of tax credit receipt

Outcome Measures

Primary Outcome Measures

  1. Rate of tax filing at 3 months: Did you file taxes this year? YES/NO [3 months]

    Self-reported tax filing status for the current year

  2. Rate of tax filing at 9 months: Did you file taxes this year? YES/NO [9 months]

    Self-reported tax filing status for the current year

Secondary Outcome Measures

  1. Parent depression at baseline [Baseline]

    Patient Health Questionnaire- 2 (score range 0-6, higher scores indicate worse depression symptoms)

  2. Parent depression at 3 months [3 months]

    Patient Health Questionnaire- 2 (score range 0-6, higher scores indicate worse depression symptoms)

  3. Parent depression at 9 months [9 months]

    Patient Health Questionnaire- 2 (score range 0-6, higher scores indicate worse depression symptoms)

  4. Child socioemotional development at 3 months [3 months]

    PEDS:DM (Parents' Evaluation of Developmental Status - Developmental Milestones): More 'yes' responses indicate more developmental milestones met

  5. Child socioemotional development at 9 months [9 months]

    PEDS:DM (Parents' Evaluation of Developmental Status - Developmental Milestones): More 'yes' responses indicate more developmental milestones met

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Income <$75,000 per year

  • One or more children under 6 years of age

  • Has a valid tax filing ID (SSN or ITIN)

  • Has access to an internet-enabled device

Exclusion Criteria:
  • Experiencing an acute mental health crisis

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of California, Los Angeles

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kristen R. Choi, PhD, RN, FAAN, Assistant Professor, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT05612685
Other Study ID Numbers:
  • 22-001575
First Posted:
Nov 10, 2022
Last Update Posted:
Nov 10, 2022
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 10, 2022